Go Mediaction

Main Menu

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis

Go Mediaction

Header Banner

Go Mediaction

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis
Drug discovery
Home›Drug discovery›OPEN CALL FOR DRUG DISCOVERY PARTNERSHIPS IN DUBAI

OPEN CALL FOR DRUG DISCOVERY PARTNERSHIPS IN DUBAI

By Deborah A. Gray
May 4, 2022
0
0

Secondcell Bio is scaling up the implementation of biotechnology from Rockefeller University for drug discovery at scale.

Secondcell Bio uses biotechnology invented at Rockefeller University to implement numerous drug discovery programs in the United Arab Emirates.

The public-private partnership in the United Arab Emirates allows us to realize the full potential of our technology for science and human health.

— Dr. Kambiz Shekdar, inventor

NEW YORK, NY, USA, May 4, 2022 /EINPresswire.com/ — Today Secondcell biography announces an open call for academic and industry drug discovery advisors and partnerships.

Similar to the scale-up of automated DNA sequencing methods that ushered in the era of the Human Genome Project, Secondcell Bio uses robotic, scalable technology invented at Rockefeller University for scale-up. of its technology in a factory-like public-private partnership in the United Arab Emirates. to discover and develop new pharmaceutical drugs.

“Our transformative cell biotechnology uses Molecular Lightbulbs™ to remove bottlenecks in cell-based drug discovery. The public-private partnership in the UAE allows us to fully harness the potential of our technology for science and human health,” says Dr. Shekdar, PhD, inventor and founder of Secondcell Bio.

Secondcell Bio is a private biotechnology company with access to the core technology and know-how developed by its founder. The technology was developed with over $100 million in funding from private sources and with no funding from the NIH or other US government, making it a rare and mature cutting-edge biotechnology, unencumbered and available for the exporting and franchising globally.

Currently, Secondcell Bio is looking to build a strong team of scientific and medical advisors around the world. In particular, researchers and research institutions from the UAE and the region are encouraged to reach out.

Priority areas include refractory diseases for which newly identified drug targets have been reported, systems biology applications including diseases mediated by large gene families and heteromultimeric targets, and disease variants representing populations under-represented, rare and orphan indications.

The partnership is poised to open up new territory in drug discovery and development, including for personalized medicine, leveraging an individual’s human genome data to develop new drugs. This is made possible because Secondcell Bio’s technology enables the implementation of personalized drug discovery and development that is both rapid and cost effective. Researchers who have identified potential drug targets or SNPs for one or more individuals are strongly encouraged to get in touch to explore personalized drug discovery partnerships.

ABOUT SECONDECELL BIO

Secondcell Bio is setting up a public-private partnership in the United Arab Emirates to develop its demonstrated and largely automated biotechnology platform originating from Rockefeller University. Called, Chromovert® The technology, method, and a variety of example results for the platform technology can be found here: https://link.springer.com/article/10.1007/s10529-021-03101-5.

J. Dianne Dotson
Secondcell biography
write to us here

You just read:

News provided by

04 May 2022, 12:00 GMT


EIN Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to be careful not to weed out false and misleading content. As a user, if you see something we missed, please bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™, attempts to define some of the boundaries that are reasonable in today’s world. Please see our editorial guidelines for more information.

Submit your press release

Categories

  • Drug discovery
  • Medical diagnosis
  • Medical field
  • Prescription drugs

Recent Posts

  • Fujitsu and RIKEN launch joint research on drug discovery technology using Fugaku
  • Medical diagnostics and technology reshaping medical communication
  • Drug discovery pioneer Verseon achieves breakthrough once predicted by Steve Jobs
  • World’s first 3D insights into malaria parasites bolster drug discovery pipeline
  • Legal weed lowers prescription drug use, study finds

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • September 2020
  • May 2020
  • March 2020
  • September 2019
  • May 2019
  • August 2018
  • December 2013
  • Privacy Policy
  • Terms and Conditions